FIGURE

Fig. 9

ID

ZDB-FIG-250609-108

Publication

Kuo et al., 2025 - The histamine pathway is a target to treat hepatic experimental erythropoietic protoporphyria

Other Figures

All Figure Page

Back to All Figure Page

Fig. 9

Gene mRNA and protein expressions of heme biosynthesis enzymes. (A) ALAS1, ALAD, HMBS, PPOX, and FECH gene expressions are suppressed in the female fch/fch liver. ALAS1, UROD, and FECH gene expressions are suppressed in the male fch/fch liver. (B) Standard immunoblotting was carried with similar protein loading for each of the displayed panels. The ALAS1, FECH, ALAD, and UROD protein expression is suppressed in the fch/fch livers. Under the experimental conditions used in this study, HMW aggregates of ALAD and UROD (and not ALAS1 or FECH) were detected in the fch/fch livers. There is an upward shift in ALAD and UROD monomers as indicated by the arrowheads. Data are shown as mean ± SD (n = 2–3 livers per group). Statistical analysis was performed by 1-way ANOVA test, ∗∗∗P < .001; ∗∗P < .01; ∗P < .05

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cell Mol Gastroenterol Hepatol